Is Investing in France Risky?
⸻
Investing in France remains an attractive proposition for international investors. The country offers a highly skilled workforce, strong industrial capabilities, and direct access to the European Union market.
However, investing in France is not purely an economic or financial decision.
It is a regulated environment where transactions—especially in strategic sectors—are subject to increasing scrutiny. For foreign investors, the success of an investment depends not only on valuation or market opportunity, but on regulatory acceptability.
This distinction is critical.
In France, a well-structured deal can fail if regulatory risks are not properly anticipated.
⸻
A market open to investment—but not without conditions
France actively promotes foreign investment. Public authorities regularly emphasize the country’s attractiveness, supported by:
• a diversified industrial base
• strong innovation ecosystems
• government incentives for strategic sectors
• a central position within the European Union
At first glance, investing in France appears straightforward.
Yet, this openness coexists with a robust regulatory framework designed to protect national interests.
This framework does not prevent investment—but it conditions it.
⸻
The rise of regulatory risk in France
For foreign investors, regulatory risk has become a central parameter when investing in France.
This risk is not limited to formal legal constraints. It includes a broader set of factors:
• foreign direct investment (FDI) screening
• sector-specific regulations
• political and institutional considerations
• public perception of the transaction
In practice, regulatory risk introduces uncertainty into the execution of a deal.
The key issue is not whether a transaction is legally possible—but whether it is acceptable to the authorities.
⸻
FDI screening: a core component of investing in France
One of the most significant regulatory mechanisms affecting investing in France is the foreign direct investment screening regime.
Under the French Monetary and Financial Code, certain investments by foreign investors require prior authorization from the Ministry of the Economy.
This applies when three cumulative criteria are met:
• the investor qualifies as a foreign investor
• the transaction involves control, acquisition of a business, or certain thresholds of voting rights
• the target operates in a sensitive sector
Sensitive sectors include, among others:
• defense and national security
• critical infrastructure
• energy and transportation
• telecommunications
• data and digital technologies
• health and biotechnology
For investors, this means that investing in France may require regulatory approval before closing the transaction.
Failure to anticipate this requirement can delay—or block—the deal entirely.
⸻
Beyond law: understanding the role of the State
A common misconception among international investors is to approach investing in France purely through a legal lens.
In reality, the State plays a broader role.
Even when not formally intervening as a shareholder, public authorities influence transactions through:
• authorization processes
• informal guidance
• political signaling
• strategic considerations
This introduces what can be described as “State risk.”
State risk is not arbitrary—but it is not purely legal either.
It reflects how a transaction aligns with national priorities such as:
• economic sovereignty
• industrial policy
• protection of critical capabilities
• employment considerations
Understanding this dimension is essential when investing in France.
⸻
Sensitive sectors: where risks are concentrated
Regulatory risk is not uniform across all investments.
It is concentrated in sectors considered strategic.
Investing in France in these sectors requires heightened vigilance, including:
• early identification of regulatory exposure
• detailed analysis of the target’s activities
• mapping of potential sensitivities
In these contexts, transactions are assessed not only on economic grounds, but on their broader impact.
For example:
• Will the investment affect national security?
• Does it involve critical technologies?
• Could it lead to a loss of strategic know-how?
These questions are central to the regulatory review process.
⸻
Timing risk: the underestimated factor
Another critical aspect of investing in France is timing.
Regulatory processes—particularly FDI screening—introduce structured timelines that can affect deal execution.
In most cases:
• an initial review phase is conducted
• additional investigations may follow
• conditions may be imposed before approval
For investors, this creates several constraints:
• uncertainty in deal scheduling
• potential delays in closing
• renegotiation of transaction terms
Timing risk is often underestimated during the early stages of a transaction.
Yet, it can be decisive.
⸻
Strategic structuring: a key success factor
Successfully investing in France requires more than compliance.
It requires strategic structuring of the transaction.
This includes:
• anticipating regulatory triggers
• aligning the deal structure with State expectations
• preparing a coherent narrative around the investment
• identifying potential mitigation measures
In practice, this may involve:
• adjusting governance structures
• defining commitments to the authorities
• structuring the investment in phases
The objective is clear: reduce uncertainty and increase the probability of approval.
⸻
Common mistakes foreign investors make
When investing in France, foreign investors often make recurring mistakes.
These include:
1. Treating regulation as a secondary issue
Regulatory considerations are addressed too late in the process.
2. Underestimating State expectations
Investors focus on legal compliance but ignore strategic alignment.
3. Misjudging sensitive activities
Targets are incorrectly assessed as non-sensitive.
4. Failing to anticipate timing constraints
Deal timelines do not integrate regulatory processes.
5. Approaching the process defensively
Investors react to regulatory issues instead of anticipating them.
These mistakes can significantly increase execution risk.
⸻
Investing in France: from risk to opportunity
While regulatory risk is real, it should not be seen solely as a constraint.
For well-prepared investors, it can become a differentiating factor.
Investing in France successfully often means:
• demonstrating long-term commitment
• aligning with national priorities
• structuring transactions intelligently
• engaging proactively with the regulatory framework
In this sense, regulatory complexity creates a barrier to entry—but also an opportunity.
Investors who understand the system gain a competitive advantage.
⸻
How to secure your investment in France
To mitigate risks when investing in France, investors should adopt a structured approach:
Early-stage assessment
Identify whether the transaction may trigger regulatory review.
Regulatory mapping
Analyze the applicable frameworks and stakeholders.
Strategic positioning
Define how the investment aligns with public interests.
Execution planning
Integrate regulatory timelines into the deal process.
Proactive engagement
Anticipate questions and prepare responses before filing.
This approach transforms regulatory risk into a manageable variable.
⸻
Final insight: investing in France requires a shift in mindset
The key takeaway is simple:
Investing in France is not just about acquiring an asset.
It is about securing approval.
This requires a shift from a purely transactional mindset to a strategic one.
Investors must integrate:
• legal analysis
• political understanding
• institutional dynamics
Only then can they fully control execution risk.
⸻
Strategic Assessment for Foreign Investors
Before moving forward with a transaction, a critical question should be addressed:
Is your investment exposed to regulatory risk in France?
A structured assessment allows investors to:
• determine whether FDI screening is triggered
• identify sensitive aspects of the deal
• anticipate potential objections
• define an appropriate strategy
At Relians, this assessment is designed as a decision-making tool—not a legal formality.
It provides investors with a clear view of:
• their regulatory exposure
• the feasibility of the transaction
• the conditions required to secure approval
In an environment where investing in France increasingly depends on regulatory alignment, early clarity is not optional.
It is a prerequisite for execution.
⸻
